Supplementary Figures from Vertical Inhibition of the RAF–MEK–ERK Cascade Induces Myogenic Differentiation, Apoptosis, and Tumor Regression in <i>H/NRAS<sup>Q61X</sup></i> Mutant Rhabdomyosarcoma
Natalia García, Angelina V. Vaseva(The University of Texas at San Antonio Health Science Center), Marielle E. Yohe(National Cancer Center), Anna Rogojina, Kris C. Wood(Duke University), Sara Zimmerman(National Institutes of Health), Myron S. Ignatius(The University of Texas at San Antonio Health Science Center), Kunal Baxi(The University of Texas at San Antonio Health Science Center), Craig M. Goodwin(University of North Carolina at Chapel Hill), Terry J. Shackleford(The University of Texas at San Antonio Health Science Center), William D. Figg(National Cancer Institute), Long Wang(Hubei University of Medicine), Yidong Chen(The University of Texas at San Antonio Health Science Center), Vanessa Del Pozo, Peter J. Houghton(King's College London), Cody J. Peer(National Institutes of Health)
Cited by 0
Related Papers
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation
|Journal of Clinical Investigation|2014|717
Treatment With Carfilzomib-Lenalidomide-Dexamethasone With Lenalidomide Extension in Patients With Smoldering or Newly Diagnosed Multiple Myeloma
|JAMA Oncology|2015|309
2‐Methoxyestradiol, a Promising Anticancer Agent
|Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy|2003|276